Market Moves
Science Corp Raises $230 Million to Commercialise PRIMA Retinal Implant
Science Corporation closes a $230 million Series C led by Khosla Ventures and Lightspeed, pushing its valuation past $1 billion as it targets European launch of the PRIMA vision-restoration implant by mid-2026.